KENNETH DOVIDIO: Open Payments
NPI 1891812061 · NORTH ANDOVER, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,220 in 59 payments from 15 companies in 2025. Trend: 2023 $1,507 · 2024 $1,145 · 2025 $1,220
Food & beverage: $1,187Education: $32
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 17 | $326 |
| Novo Nordisk Inc | 6 | $134 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $95 |
| ABBVIE INC. | 4 | $92 |
| Gilead Sciences, Inc. | 4 | $81 |
| PFIZER INC. | 4 | $77 |
| ViiV Healthcare Company | 2 | $67 |
| E.R. Squibb & Sons, L.L.C. | 3 | $58 |
| Lilly USA, LLC | 3 | $54 |
| TOLMAR, INC. | 2 | $53 |
Products named: BREZTRI, FARXIGA, JARDIANCE, AIRSUPRA, ELIQUIS, Rybelsus, APRETUDE, JATENZO.
Industry payments across MA — which companies pay providers there.
